Cargando…
Challenges and lessons learned from four years of planning and implementing pharmacovigilance enhancement in sub-Saharan Africa
Pharmacovigilance (PV) systems in many countries in sub-Saharan Africa (SSA) are not fully functional. The spontaneous adverse events (AE) reporting rate in SSA is lower than in any other region of the world, and healthcare professionals (HCPs) in SSA countries have limited awareness of AE surveilla...
Autores principales: | Stegmann, Jens-Ulrich, Jusot, Viviane, Menang, Olga, Gardiner, Gregory, Vesce, Sabino, Volpe, Stephanie, Ndalama, Anderson, Adou, Felix, Ofori-Anyinam, Opokua, Oladehin, Olakunle, Mendoza, Yolanda Guerra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9383683/ https://www.ncbi.nlm.nih.gov/pubmed/35978276 http://dx.doi.org/10.1186/s12889-022-13867-6 |
Ejemplares similares
-
Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi
por: Jusot, Viviane, et al.
Publicado: (2020) -
Correction to: Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi
por: Jusot, Viviane, et al.
Publicado: (2021) -
Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa
por: Guerra Mendoza, Yolanda, et al.
Publicado: (2019) -
Baseline assessment of pharmacovigilance activities in four sub-Saharan African countries: a perspective on tuberculosis
por: Tiemersma, Everdina W., et al.
Publicado: (2021) -
Strategies and interventions to strengthen pharmacovigilance systems in low-income and middle-income countries: a scoping review
por: Menang, Olga, et al.
Publicado: (2023)